Volume : 08, Issue : 06, June – 2021
Title:
22.REVIEW ON EMULGEL A NOVEL APPROACH FOR TOPICAL DRUG DELIVERY SYSTEM
Authors :
Aswini K, Praveen Sivadasu* and Padmalatha K
Abstract :
Emulgel is currently attracting researchers for its potential as a drug delivery system by loading a broad range of drug molecules. Emulgel is formed by incorporating either o/w or w/o emulsion in a gel base formed by a gelling agent. By incorporating emulsion into a gel enhances the stability and makes it a dual control release system. When compared with other topical drug delivery systems emulgel shows better drug release and enhanced patient compliance due to the presence of soluble excipients. The current review gives an overview of ideal properties with special emphasis on the formulation and evaluation of emulgel.
Keywords: Emulgel; Emulsion; Gelling agent; Dual controlled release; Topical agents
Cite This Article:
Please cite this article in press Sivadasu Praveen et al., Review On Emulgel A Novel Approach For Topical Drug Delivery System.., Indo Am. J. P. Sci, 2021; 08(06).
Number of Downloads : 10
References:
[1] Kshirsagar N A. Drug Delivery Systems. Ind. J. Pharmacol. 2000; 32:S54- 61.
[2] Zi P , Yang X, Kuang H, Yang Y, Yu L: Effect of HP-beta CD on solubility and transdermal delivery of capsaicin through rat skin. Int. J. Pharm. 2008; 358: 151–8.
[3] Shokri J, Azarmi S, Fasihi Z: Effect of various penetration enhancers on percutaneous absorption of piroxicam from emulgel. Res. Pharm. Sci. 2012; 7: 2225–34.
[4] Foldvari M: Non-invasive administration of drugs through the skin: challenges in delivery system design. Pharm. Sci. Technol. Today. 2000; 3: 417–25.
[5] Mohamed MI: Optimization of chlorphenesin emulgel formulation. AAPS J..2004; 6(3): 81-7.
[6] Alexander A, Ajazuddin, Tripathi DK, Vrema ST, Maurya J, Patel S: Mechanism responsible for mucoadhesion of mucoadhesive drug delivery system: a review. Int. J. Appl. Biol. Pharm. Technol. 2011; 2: 434–45.
[7] Elbayoumi TA, Torchilin VP: Liposomes for targeted delivery of antithrombotic drugs. Expert Opin. Drug Deliv. 2008; 5 1185–98.
[8] Torchilin V: Antibody-modified liposomes for cancer chemotherapy. Expert Opin. Drug Deliv. 2008; 5: 1003– 25.
[9] Panwar AS, Upadhyay N, Bairagi M, Gujar S, Darwhekar GN, Jain DK: Emulgel: a review, Asian J. Pharm. Life Sci. 2011;1:2231–4423.
[10] Kumar NPM, Patel MR, Patel KR, Patel NM: Emulgels: a novel approach to topical drug delivery. Int. J. Univ. Pharm. Bio Sci. 2013; 2: 134–48.
[11] Hu L, Yang J, Liu W, Li L: Preparation and evaluation of Ibuprofen-loaded microemulsion for improvement of oral bioavailability. Drug Deliv. 2011; 18: 90–5.
[12] Dickinson E: Hydrocolloids as emulsifiers and emulsion stabilizers. Food Hydrocolloids 2009; 23: 1473–82.
[13] Misra AN, Jain NK. Controlled and novel drug delivery. Transdermal Drug Delivery New Delhi, India: CBS Publisher and Distributor. 1997:100-1.
[14] Yadav SK, Mishra MK, Tiwari AN, Shukla A. Emulgel: a new approach for enhanced topical drug delivery. Int J Curr Pharm Res. 2016; 9(1):15-9.
[15] Shingade GM, Aamer Q, Sabale, Grampurohit ND, Gadhave MV: Review on: recent trend on transdermal drug delivery system. J. Drug Dev. Ther. 2012; 2 (1): 66– 75.
[16] Cecv G, Mazgareanu S, Rother M. Preclinical characterisation of NSAIDs in ultra deformable carriers or conventional topical gels. Int J Pharm. 2008; 360:29-39.
[17] Elias PM, Menon GK. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res. 1991; 24:1-26.
[18] . Butler H. Poucher’s perfumes cosmetics and soaps. 10th 16. Bruton L, Keith P, Blumenthal D, Buxton L. Goodman and Gillman’s manual of pharmacology and therapeutics. 2 ed. Springer, India; 2010. p. 402
[19] Lachman L, Lieberman HA. The Theory and Practice of Industrial Pharmacy. 3 ed. Mc Graw’s Hill; Varghese Publishing house; 1990. p. 534.
[20] Beitz JM: Heparin induced thrombocytopenia syndrome bullous lensions treated with trypsin-balsam of peru-castor oil ointment: a case study. Ostmony Wound Manage. 2005; 51: 52–4.
[21] Vilasau J, Solans C, Gómez MJ, Dabrio J, Mújika-Garai R, Esquena J: Phase behaviour of a mixed ionic/nonionic surfactant system used to prepare stable oil-in-water paraffin emulsions. Colloids Surf. A Physicochem. Eng. Asp. 2011; 384: 473–81.
[22] Baibhav J, Singh G, Rana AC, Saini S: Development and Characterization of Clarithromycin Emulgel for topical delivery. IJDDR. 2012; 4(3): 310-23.
[23] Patel RP, Patel G, Baria A: Formulation and evaluation of transdermal patch of aceclofenac. Int. J. Drug Del. 2009; 1: 41 – 51.
[24] Baibhav J, Singh G, Rana A. C., Saini S, Singla V: Emulgel: A Comprehensive Review on The Recent Advances In Topical Drug Delivery. Int. Res. J. Pharm.2011; 2(11); 66-70.
[25] Aher S. D, Banerjee S.K, Gadhave M.V, Gaikawad D.D: Emulgel: a new dosage form for topical drug delivery. IJIPLS. 2013; 3(3): 1-10.
[26] Ranga PM, Sellakumar V, Natarajan R, Mohan KK. Formulation and In-vitro evaluation of ciprofloxacin-loaded topical emulgel. Int J Pharm Chem Sci. 2012;1: 237-42.
[27] Prajapati Mehulkumar N, Patel M R, Patel K R and Patel N M: Emulgels: a novel approach to topical drug delivery. IJUPBS. 2013; 2(1): 134-48.
[28] Khalil YI, Khasraghi AH, Mohammed EJ. Preparation and evaluation of physical and, rheological properties of clotrimazole emulgel: Iraqi J Pharm Sci. 2011; 20(2): 19- 27.
[29] Singla V, Saini S, Joshi B, Rana AC. Emulgel: A new platform for topical drug delivery. Int J Pharma Bio Sci. 2012; 3(1):485-98.
[30] Trommer H, Neubert RHH: Overcoming the stratum corneum the modulation of skin penetration. Skin Pharmacol Physiol. 2006; 19:106-21.
[31] Washitake M, Takashima Y, Tanaka S, Anmo T, Tanaka I Drug permeation through egg shell membranes. Chern. Pharm. Bull.1980; 28:2855-61.
[32] Guideline IH. Stability testing of new drug substances and products. Q1A (R2), current step. 2003; 4:1-24.